If you are a business wanting to schedule multiple employees, please call the pharmacy at 870-423-2094 instead of using the website scheduler.

ATTENTION ALL MEDICARE CUSTOMERS:

Significant Changes to Medicare Part D Plans in 2024 that can affect you!

~ WE ARE LIMITED ON THE PLANS WE CAN TAKE ~

Learn how Economy Drug is addressing these changes – click here to read more.

Get Healthy!

  • Posted December 29, 2022

Some Young Cancer Survivors Won't Get Cancer-Preventing HPV Vaccine

Young cancer survivors face a heightened risk from human papillomavirus (HPV), a virus known to raise the risk of cervical cancer. So why are they getting the HPV vaccine in low numbers?

To find out, researchers analyzed data from a clinical trial of the HPV vaccine among cancer survivors who were ages 9 to 26 and were one to five years from the completion of their cancer treatment.

The survivors, or their parents in the case of minors, who declined participation in the trial were asked about their reasons.

More than 70% of the 301 survivors who declined to participate in the clinical trial did so because of the HPV vaccines. They reported concerns about vaccine safety, such as "hearing bad things about the vaccine." They also reporting viewing the vaccine as "unnecessary" or wanted to wait until their children were older.

Some of the survivors said they had already "been through so much" and wanted to avoid additional medical interventions. Others received guidance from a health care provider to delay or decline the vaccine "because of all the treatment he's had."

Researchers said that findings, published Dec. 19 in the journal CANCER, may help health care providers address patient, and parent, concerns about vaccination.

"The HPV vaccine is an important tool for cancer prevention, particularly for the vulnerable population of cancer survivors," said Brooke Cherven, a researcher at Winship Cancer Institute of Emory University in Atlanta.

"By incorporating messages that address common concerns, health care providers may feel more prepared and confident when recommending the HPV vaccine to survivors in their practice," Cherven said in a journal news release.

More information

The U.S. Centers for Disease Control and Prevention has more on human papillomavirus.

SOURCE: CANCER, news release, Dec. 19, 2022

Health News is provided as a service to Economy Drug site users by HealthDay. Economy Drug nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2024 HealthDay All Rights Reserved.